FDA Expands Use of Bristol Myers’ Cancer Cell Therapy
May 17, 2024 : The U.S. Food and Drug Administration (FDA) has granted expanded use for Bristol Myers Squibb’s CAR-T cell therapy, Breyanzi
Menu
Day: May 17, 2024
May 17, 2024 : The U.S. Food and Drug Administration (FDA) has granted expanded use for Bristol Myers Squibb’s CAR-T cell therapy, Breyanzi
